1. Home
  2. ANL vs ARHS Comparison

ANL vs ARHS Comparison

Compare ANL & ARHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adlai Nortye Ltd.

ANL

Adlai Nortye Ltd.

HOLD

Current Price

$15.11

Market Cap

998.8M

Sector

N/A

ML Signal

HOLD

Logo Arhaus Inc.

ARHS

Arhaus Inc.

BUY

Current Price

$10.16

Market Cap

956.8M

ML Signal

BUY

Company Overview

Basic Information
Metric
ANL
ARHS
Founded
2004
1986
Country
Singapore
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
998.8M
956.8M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
ANL
ARHS
Price
$15.11
$10.16
Analyst Decision
Strong Buy
Buy
Analyst Count
7
15
Target Price
★ $29.50
$10.54
AVG Volume (30 Days)
143.5K
★ 1.4M
Earning Date
08-14-2026
11-05-2026
Dividend Yield
N/A
★ 3.42%
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.30
Revenue
N/A
★ $1,379,222,000.00
Revenue This Year
$243.83
$5.89
Revenue Next Year
N/A
$6.43
P/E Ratio
★ N/A
$32.90
Revenue Growth
N/A
★ 8.51
52 Week Low
$0.88
$5.57
52 Week High
$17.25
$12.08

Technical Indicators

Market Signals
Indicator
ANL
ARHS
Relative Strength Index (RSI) 50.08 65.95
Support Level $14.70 $9.81
Resistance Level $15.29 $10.45
Average True Range (ATR) 1.02 0.45
MACD -0.11 0.18
Stochastic Oscillator 29.50 95.61

Price Performance

Historical Comparison
ANL
ARHS

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage company at the forefront of discovering and developing cancer therapies. The company is building a robust pipeline of drug candidates focused on two key areas where it believes it can make a difference RAS-targeting therapies: its is tackling RAS-driven cancers with AN9025, an oral pan-RAS(ON) inhibitor, and AN4035, a CEACAM5-targeting ADC delivering a potent pan-RAS(ON) inhibitor directly to tumors; Next-generation cancer immunotherapies: its candidates, AN8025 (a tri-functional fusion protein of alphaPD-L1 x CD86 variant x LAG3 variant), a T-cell and antigen-presenting cell modulator, and AN4005 (a first-in-class oral small-molecule PD-L1 inhibitor), are designed to activate cancer immunity in novel ways.

About ARHS Arhaus Inc.

Arhaus Inc is a growing lifestyle brand and omnichannel retailer of premium home furniture. The company offers merchandise in several categories, including furniture, outdoor, lighting, textiles, and decor through its Retail and e-commerce sales channels.

Share on Social Networks: